Fri, May 1, 2020
Thu, April 30, 2020
Wed, April 29, 2020

Andrew Berens Maintained (BPMC) at Buy with Decreased Target to $88 on, Apr 30th, 2020


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. ith-decreased-target-to-88-on-apr-30th-2020.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Andrew Berens of Morgan Stanley, Maintained "Blueprint Medicines Corporation" (BPMC) at Buy with Decreased Target from $103 to $88 on, Apr 30th, 2020.

Andrew has made no other calls on BPMC in the last 4 months.



There are 3 other peers that have a rating on BPMC. Out of the 3 peers that are also analyzing BPMC, 0 agree with Andrew's Rating of Hold.



These are the ratings of the 3 analyists that currently disagree with Andrew


  • Andrew Fein of "HC Wainwright & Co." Reiterated at Strong Buy with Decreased Target to $66 on, Wednesday, April 29th, 2020
  • George Farmer of "BMO Capital" Maintained at Buy with Decreased Target to $75 on, Wednesday, April 29th, 2020
  • Konstantinos Aprilakis of "JMP Securities" Maintained at Buy with Decreased Target to $103 on, Wednesday, April 29th, 2020

Publication Contributing Sources